Journal article
Novel and ultra-rare damaging variants in neuropeptide signaling are associated with disordered eating behaviors
PloS one, Vol.12(8), pp.e0181556-e0181556
2017
DOI: 10.1371/journal.pone.0181556
PMCID: PMC5573281
PMID: 28846695
Abstract
Eating disorders develop through a combination of genetic vulnerability and environmental stress, however the genetic basis of this risk is unknown.
To understand the genetic basis of this risk, we performed whole exome sequencing on 93 unrelated individuals with eating disorders (38 restricted-eating and 55 binge-eating) to identify novel damaging variants. Candidate genes with an excessive burden of predicted damaging variants were then prioritized based upon an unbiased, data-driven bioinformatic analysis. One top candidate pathway was empirically tested for therapeutic potential in a mouse model of binge-like eating.
An excessive burden of novel damaging variants was identified in 186 genes in the restricted-eating group and 245 genes in the binge-eating group. This list is significantly enriched (OR = 4.6, p<0.0001) for genes involved in neuropeptide/neurotrophic pathways implicated in appetite regulation, including neurotensin-, glucagon-like peptide 1- and BDNF-signaling. Administration of the glucagon-like peptide 1 receptor agonist exendin-4 significantly reduced food intake in a mouse model of 'binge-like' eating.
These findings implicate ultra-rare and novel damaging variants in neuropeptide/neurotropic factor signaling pathways in the development of eating disorder behaviors and identify glucagon-like peptide 1-receptor agonists as a potential treatment for binge eating.
Details
- Title: Subtitle
- Novel and ultra-rare damaging variants in neuropeptide signaling are associated with disordered eating behaviors
- Creators
- Michael Lutter - Eating Recovery Center of Dallas, Plano, Texas, United States of AmericaEthan Bahl - Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, Iowa, United States of AmericaClaire Hannah - Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, Iowa, United States of AmericaDabney Hofammann - Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, Iowa, United States of AmericaSummer Acevedo - Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of AmericaHuxing Cui - Department of Pharmacology, University of Iowa, Carver College of Medicine, Iowa City, Iowa, United States of AmericaCarrie J McAdams - Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of AmericaJacob J Michaelson - Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, Iowa, United States of America
- Resource Type
- Journal article
- Publication Details
- PloS one, Vol.12(8), pp.e0181556-e0181556
- DOI
- 10.1371/journal.pone.0181556
- PMID
- 28846695
- PMCID
- PMC5573281
- NLM abbreviation
- PLoS One
- ISSN
- 1932-6203
- eISSN
- 1932-6203
- Publisher
- Public Library of Science; United States
- Grant note
- K23 MH093684 / NIMH NIH HHS T32 GM008629 / NIGMS NIH HHS R01 MH105527 / NIMH NIH HHS
- Language
- English
- Date published
- 2017
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Communication Sciences and Disorders; Psychiatry; Iowa Neuroscience Institute; Fraternal Order of Eagles Diabetes Research Center; Neuroscience and Pharmacology
- Record Identifier
- 9984040438502771
Metrics
18 Record Views